Armelle Dufresne and Timothée Olivier discuss research progresses in the latest ESMO interview
ESMO posted on LinkedIn:
“Ahead of ESMO Rare Cancers 2025, Armelle Dufresne and Timothée Olivier discuss research progresses in the field, analyse the regulatory boundaries and highlight the crucial role of knowledge and data sharing among the stakeholders in the field.”
Quoting ESMO’s post below:
“Rare Disease Day: Reflecting the 2025 theme ‘More Than You Can Imagine’, Rare Cancers, when considered collectively, are more common than one might think. Research into rare cancers progresses at a slower pace than other areas of oncology, although there is a pressing healthcare need.
With ESMO Rare Cancers, the most recent Open Access journal established by ESMO, the Society supports knowledge and data sharing among stakeholders to improve care for patients with rare malignancies.
In this interview with the ESMO Daily Reporter, Co-Editors-in-Chief Armelle Dufresne and Timothée Olivier discuss the crucial roles of awareness, medical workforce education, policy considerations, and collaboration in advancing research.
Read the full interview in the ESMO Daily Reporter.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023